Q4 2024 Holdings
Filed 2025-02-14 | 40 holdings | $95.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $15.8M | 175,000 | 16.5% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $12.8M | 25,000 | 13.4% |
| Ishares TR(TLT)Put | 20 YR TR BD ETF | 464287432 | $8.7M | 100,000 | 9.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.8M | 284,517 | 5.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $4.8M | 431,117 | 5.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $4.5M | 100,000 | 4.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $4.3M | 591,253 | 4.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.1M | 479,100 | 4.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $3.8M | 1,515,126 | 4.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.5M | 120,000 | 3.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.1M | 65,000 | 3.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $2.7M | 35,000 | 2.8% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $2.6M | 80,000 | 2.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.3M | 65,000 | 2.4% |
| TG Therapeutics Inc(TGTX)Call | COM | 88322Q108 | $2.3M | 75,000 | 2.4% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.3M | 850,684 | 2.4% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $1.2M | 150,000 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.2M | 30,000 | 1.2% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $997.7K | 950,166 | 1.0% |
| Merus N V | COM | N5749R100 | $914.0K | 21,735 | 1.0% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $904.8K | 130,000 | 0.9% |
| Rallybio Corp | COM | 75120L100 | $771.3K | 803,398 | 0.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $753.0K | 13,600 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $690.4K | 10,000 | 0.7% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $662.0K | 50,000 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $554.5K | 613,028 | 0.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $545.0K | 25,000 | 0.6% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $544.7K | 73,314 | 0.6% |
| Olema Pharmaceuticals Inc(OLMA)Call | COM | 68062P106 | $524.7K | 90,000 | 0.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $496.0K | 9,700 | 0.5% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $470.4K | 22,000 | 0.5% |
| Biomx Inc | COM NEW | 09090D301 | $470.1K | 643,833 | 0.5% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $441.0K | 244,988 | 0.5% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $412.0K | 100,000 | 0.4% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $387.8K | 20,000 | 0.4% |
| Zura BIO LTD(ZURA)Call | CLASS A ORD SHS | G9TY5A101 | $250.0K | 100,000 | 0.3% |
| Elevation Oncology Inc | COM | 28623U101 | $243.2K | 432,206 | 0.3% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $184.9K | 195,111 | 0.2% |
| Viridian Therapeutics Inc(VRDN)Put | COM | 92790C104 | $69.0K | 3,600 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $33.3K | 5,054 | 0.0% |